Rheumatology

Top Story

RA not a risk factor for CV mortality in ESRD

RA not a risk factor for CV mortality in ESRD
May 21, 2018
Meeting News

IgG4 serum insufficient to diagnose IgG4-related disease

May 21, 2018
DESTIN, Fla. —An over-reliance on elevations in serum immunoglobin G4 concentrations, or tissue immunoglobin G4-positive plasma cell numbers, remain significant…
Meeting News

Weekly Actemra improves health-related quality of life, fatigue in GCA

May 20, 2018
DESTIN, Fla. — In patients with giant cell arteritis, a regimen of tocilizumab given 162 mg weekly plus a 26-week prednisone taper demonstrated significant…
Meeting News

GPA, PR3-ANCA predictors of vasculitis relapse

May 20, 2018
DESTIN, Fla. — Practical, individualized care for patients with antineutrophil cytoplasmic antibody-associated vasculitis should use the presence of granulomatosis…
More Headlines »
CME

Best of AWIR Immunology Bootcamp

This activity is supported by educational grants from AbbVie, Inc.; Lilly USA, LLC; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Immune-mediated inflammatory disease (IMID) is a group of clinically heterogeneous disorders that share common…
More »
GI Bookshelf

Chapter 29: Management of Crohn’s Disease in the Ileal-Pouch Anal Anastomosis

From Crohn's Disease: The Complete Guide to Medical Management
More »
Resource Centers
Video
Meeting News

VIDEO: No increased safety risk associated with increasing tocilizumab exposure

December 4, 2017
More »